NEW YORK (GenomeWeb) – Despite their efficacy as gene-editing technologies, CRISPR/Cas9 and TALENs are still hampered by the potential for off-target activity, which can result in genome instability and impair normal gene function. But a new strategy reported this week, which had previously been developed for a related technology, promises to help researchers measure such unintended effects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.